Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)
Open Access
- 1 March 1991
- Vol. 67 (5), 1305-1310
- https://doi.org/10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsCancer, 1990
- Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumorsCancer, 1990
- A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.Journal of Clinical Oncology, 1988
- Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimenCancer, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.Journal of Clinical Oncology, 1987
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.Journal of Clinical Oncology, 1985
- Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsAmerican Journal Of Medicine, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958